Apellis Pharmaceuticals shares owned by Cormorant Asset Management
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Cormorant Asset Management
from 13F filings
Historical chart of Cormorant Asset Management investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Cormorant Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $37M | 625k | 59.86 |
| 2023-09-30 | $76M | 2.0M | 38.04 |
| 2023-06-30 | $123M | 1.3M | 91.10 |
| 2023-03-31 | $90M | 1.4M | 65.96 |
| 2022-12-31 | $82M | 1.6M | 51.71 |
| 2022-09-30 | $101M | 1.5M | 68.30 |
| 2022-06-30 | $43M | 950k | 45.22 |
| 2022-03-31 | $57M | 1.1M | 50.81 |
| 2021-12-31 | $30M | 625k | 47.28 |
| 2021-09-30 | $31M | 925k | 32.96 |
| 2021-06-30 | $54M | 850k | 63.20 |
| 2021-03-31 | $80M | 1.9M | 42.91 |
| 2020-12-31 | $107M | 1.9M | 57.20 |
| 2020-09-30 | $56M | 1.9M | 30.17 |
| 2020-06-30 | $68M | 2.1M | 32.66 |
| 2020-03-31 | $61M | 2.3M | 26.79 |
| 2019-12-31 | $83M | 2.7M | 30.62 |
| 2019-09-30 | $72M | 3.0M | 24.09 |
| 2019-06-30 | $75M | 3.0M | 25.34 |
| 2019-03-31 | $70M | 3.6M | 19.50 |
| 2018-12-31 | $59M | 4.5M | 13.19 |
| 2018-09-30 | $74M | 4.2M | 17.78 |
| 2018-06-30 | $95M | 4.3M | 22.00 |
| 2018-03-31 | $90M | 4.1M | 22.11 |
| 2017-12-31 | $82M | 3.8M | 21.70 |
More positions owned by Cormorant Asset Management
View all positions for Cormorant Asset Management